| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |